Atai Life Sciences
 logo

Atai Life Sciences (ATAI) Q2 2024 Earnings

ATAI·Reported August 13, 2024·Before market open

Atai Life Sciences reported Q2 2024 revenue of $273.0K. Diluted EPS came in at $-0.36, missed the $-0.17 consensus by $0.19.

Revenue
$273.0K
Diluted EPS
$-0.36missed by $0.19
Consensus: $-0.17
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Atai Life Sciences 's Q2 2024 earnings report.

Atai Life Sciences (ATAI) reported Q2 2024 earnings on August 13, 2024 before market open.

Atai Life Sciences reported revenue of $273.0K and diluted EPS of $-0.36 for Q2 2024.

EPS missed the consensus estimate of $-0.17 by $0.19.

You can read the 10-Q periodic report (0000950170-24-096296) directly on SEC EDGAR. The filing index links above go to sec.gov.